Upgrade to SI Premium - Free Trial

Form 4 CVS HEALTH Corp For: Apr 01 Filed by: Bisaccia Lisa

April 3, 2019 4:58 PM
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Bisaccia Lisa
(Last) (First) (Middle)
ONE CVS DRIVE
(Street)
WOONSOCKET RI 02895
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Chief HR Officer
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/01/2019 F 2,411 (1) D $ 54.19 30,942 D
Common Stock (restricted) 12,115 D
ESOP Common Stock 600.5463 I Direct
Stock Unit 31,023.379 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 54.19 04/01/2019 A 141,405 04/01/2020 (2) 04/01/2029 Common Stock 141,405 $ 54.19 141,405 D
Phantom Stock Credits $ 1 (3) (3) Common Stock 469.5231 469.5231 D
Stock Option $ 74.29 04/01/2015 (4) 04/01/2021 Common Stock 25,177 25,177 D
Stock Option $ 102.26 04/01/2016 (5) 04/01/2022 Common Stock 34,241 34,241 D
Stock Option $ 104.82 04/01/2017 (6) 04/01/2023 Common Stock 39,433 39,433 D
Stock Option $ 78.05 04/03/2018 (7) 04/03/2024 Common Stock 55,098 55,098 D
Stock Option $ 62.21 04/01/2019 (8) 04/01/2025 Common Stock 64,222 64,222 D
Explanation of Responses:
1. Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan.
2. Option becomes exercisable in four equal annual installments, commencing 4/1/2020.
3. Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.
4. Option became exercisable in four equal annual installments, commencing 4/1/2015.
5. Option became exercisable in four equal annual installments, commencing 4/1/2016.
6. Option became exercisable in four equal annual installments, commencing 4/1/2017.
7. Option became exercisable in four equal annual installments, commencing 4/3/2018.
8. Option became exercisable in four equal annual installments, commencing 4/1/2019.
Lisa G. Bisaccia 04/03/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings